VA7-29312-60236
2 vaccinations
2 coded responses
21 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 400 / KY
- Registered
- 2021-07-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-13
Registered in v-safe
-
2021-07-13
Dose 1 — Pfizer-BioNTech
- 2021-07-13
- 2021-07-14
- 2021-07-15
- 2021-07-18
- 2021-07-19
- 2021-07-20
- 2021-07-27
- 2021-08-03
-
2021-08-05
Dose 2 — Pfizer-BioNTech
-
2021-08-06
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-08-08
- 2021-08-09
-
2021-08-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fever · Headache, Fatigue or tirednessAdult check-in
-
2021-08-12
Survey response — day 7, dose 2MedDRA: Dizziness — Feeling: Fair · Headache, Fatigue or tirednessFree text: DizzinessMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-19
- 2021-08-26
- 2021-09-02
- 2021-09-09
- 2021-09-16
- 2021-11-06
-
2022-02-03
Survey response — 6 months, dose 2MedDRA: Ageusia, Chills, Cough, Headache, Office visit, Pain, Pyrexia, Respiratory tract congestion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Fever, chills, body aches, headache, cough, congestion, loss of taste · Healthcare visit (other): Primary Care PhysicianMedDRA releases: 2024-11 · check-in free text available
-
2022-02-03
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-02-04
- 2022-08-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-13 | Pfizer-BioNTech | No |
| 2 | 2021-08-05 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-03 | Unsuccessful |
Free text
Release 9 — day 7, dose 2
Systemic reaction (other): Dizziness
Release 11 — 6 months, dose 2
Symptoms: Fever, chills, body aches, headache, cough, congestion, loss of taste
Healthcare visit (other): Primary Care Physician
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Ageusia | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SRO | Dizziness | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release